LONDON, February 20, 2013 /PRNewswire/ --
The U.S. is a major player in the global medical equipment market. With constant increase in life expectancy and aging population, the demand for medical equipments will increase. According to U.S. Central Intelligence Agency, life expectancy is 80+ years in the world's top 29 countries. Recently, there has been some action in two stocks within this segment, Stryker Corporation (NYSE : SYK) and Zimmer Holdings Inc. (NYSE : ZMH), both of which have recently posted 52- week highs. There are also some recent developments in these stocks. StockCall has posted free technical research reports on Stryker and Zimmer Holdings, and these can be accessed by signing up at
Zimmer Holdings Receives FDA Approval for Innovative Surgical Guidance Technology
Zimmer Holdings has received FDA approval to market IASSIST Knee. IASSIST Knee is a personalized guidance system for knee replacement procedures. This technology comprises of a small electronic disposable pod which provides immediate and accurate alignment validation through electronic display. Zimmer Holdings Inc. technical report can be accessed for free by signing up at
According to Jeff McCaulley, President, Zimmer Reconstructive, IASSIST technology has tremendous potential and it delivers on the promise of accurate implant positioning and alignment validation. Also they consider it as the next-step in intelligent instruments which offer significant benefits to patients and health-care providers.
Earlier this year, Zimmer had introduced V2F Anterior Fixation System. It is a new implant system for the treatment of thoracolumbar burst fractures, tumors, disc degeneration and other pathologies of the anterior spine. According to Steve Healy, President of Zimmer Spine, V2F has variable-to-fixed screw and cap technology which offers surgeons greater flexibility to tackle the unique anatomy of every patient through variable screw and plate placement and fixation.
As per Zimmer's Q4 2012 results, net sales increased by 1.1% to $1.18 billion for the fourth quarter compared to same period last year. Also, Diluted EPS for the year ending Dec 2012 as compared to same period last year increased by 6.5% to $4.29 and adjusted EPS increased by 10.4% to $5.30.
Stryker acquires Trauson Holdings to Broaden Expansion in China
According to the China National Committee on Aging, the number of Chinese senior citizens is expected to increase from the current 185 million to 487 million by 2053. China is one of the emerging markets for medical equipment. It has a huge population and also the average life expectancy of the population is high. Download the free report on Stryker Corp. upon registration at
Stryker acquired Trauson Holdings in order to expand its presence in China with a product portfolio and pipeline that is targeted at the large and fast growing value segment of the Chinese orthopaedic market.
According to Kevin A. Lobo - President and CEO of Stryker, Trauson is a convincing opportunity to drive growth in China and other emerging markets. The acquisition will create significant competitive advantages in the increasingly dynamic orthopedic industry. The main factors that will result into synergy are research and development expertise, manufacturing capabilities and strength of its distribution network.
In its Q4 2012 result Stryker posted Net sales growth of 5.5% to $2.3 billion as compared to same period last year. For the full year 2012, net sales increased by 4.2% to $8.7 billion as compared to same period last year.
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at